Patients with T2DM carrying the Pro12Ala polymorphism have higher risk of obesity than non-carriers although the same energy intake, perhaps secondary to a better insulin sensitivity [99]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.